Neuroimaging evidence of mitochondrial dysfunction and inflammation in psychiatric disorders: a review

Abstract

Mitochondrial dysfunction and neuroinflammation are two fundamental pathological processes underlying the development of psychiatric disorders. These processes are interconnected and may jointly contribute to disease progression. This article systematically reviews the progress of multimodal imaging approaches for assessing mitochondrial function, including magnetic resonance spectroscopy, PET tracers targeting mitochondrial complexes, MRI-based cerebral metabolic rate of oxygen, and emerging techniques such as T1ρ imaging and manganese-enhanced MRI, as well as neuroinflammation, including translocator protein (TSPO) PET, monoamine oxidase B PET, novel tracers targeting C3aR/IL-1β, and diffusion imaging techniques reflecting white matter microstructural alterations. These approaches have been applied to various psychiatric disorders, including schizophrenia, major depressive disorder, bipolar disorder, post-traumatic stress disorder, autism spectrum disorder, sleep disorders, and substance use disorders. Based on imaging evidence across different psychiatric disorders and cohorts, this review summarizes three transdiagnostic imaging features: impaired mitochondrial energy metabolism, alterations in glial cell immune status, and white matter microstructural alterations associated with neuroinflammation. However, although individual imaging techniques have independently identified mitochondrial dysfunction and neuroinflammation, few studies have applied dual-target imaging within the same research cohort. The direct relationship between these processes remains unverified byin vivo studies. This review outlines the shared imaging features of various psychiatric disorders and examines the utility of multimodal imaging techniques in investigating mitochondrial and neuroinflammatory pathologies. It aims to provide new insights into the diagnosis and treatment of psychiatric disorders.

Keywords

psychiatric disorders / mitochondrial dysfunction / neuroinflammation / neuroimaging / PET / MRS / TSPO

References

[1] Alcicek S, Craven AR, Shen X, et al. (2025) Multi-site feasibility and reproducibility study on UTE 3D phosphorous MRSI using novel rosette trajectory (PETALUTE). Magn Reson Med 94: 2324-34.

[2] Allen J, Romay-Tallon R, Brymer KJ, et al. (2018) Mitochondria and mood: mitochondrial dysfunction as a key player in the manifestation of depression. Front Neurosci 12: 386.

[3] Amorim FE, Rye CS, Milton AL (2025) Mitochondrial dysfunction in PTSD: a mechanism to understand trauma susceptibility? Psychopharmacology (Berl) 243: 965-88.

[4] Andica C, Kamagata K, Kirino E, et al. (2021) Neurite orientation dispersion and density imaging reveals white matter microstructural alterations in adults with autism. Mol Autism 12: 48.

[5] Ariyannur PS, Madhavarao CN, Namboodiri AM (2008) N-acetylaspartate synthesis in the brain: mitochondria vs. microsomes. Brain Res 1227: 34-41.

[6] Ballweg A, Klaus C, Vogler L, et al. (2023) [(18)F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data. J Neuroinflammation 20: 68.

[7] Balter LJ, Malmros J, Stenkrona P, et al. (2025) A [(11)C]PBR28 PET study on the associations between sleep health and microglial density. J Neuroinflammation 22: 270.

[8] Bargagna-Mohan P, Paranthan RR, Hamza A, et al. (2010) Withaferin A targets intermediate filaments glial fibrillary acidic protein and vimentin in a model of retinal gliosis. J Biol Chem 285: 7657-69.

[9] Ben-Shachar D, Karry R (2007) Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2. PLoS One 2: e817.

[10] Bertrand A, M. Hoang D, Khan U, et al. (2011) From axonal transport to mitochondrial trafficking: what can we learn from manganese-enhanced MRI studies in mouse models of Alzheimers disease? Curr Med Imaging Rev 7: 16-27.

[11] Best LM, Truong J, McCluskey T, et al. (2025) MAO-B status in alcohol use disorder: a [(11)C]SL25.1188 PET imaging study of putative astrogliosis. Mol Psychiatry 31: 2191-201.

[12] Bhatt S, Hillmer AT, Girgenti MJ, et al. (2020) PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies. Nat Commun 11: 2360.

[13] Biechele G, Franzmeier N, Blume T, et al. (2020) Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. J Neuroinflammation 17: 374.

[14] Biondetti E, Cho J, Lee H (2023) Cerebral oxygen metabolism from MRI susceptibility. Neuroimage 276: 120189.

[15] Bonomi R, Hillmer AT, Woodcock E, et al. (2024) Microglia-mediated neuroimmune suppression in PTSD is associated with anhedonia. Proc Natl Acad Sci USA 121: e2406005121.

[16] Bravi B, Bollettini I, Di Pasquasio C, et al. (2022) Brain spectroscopic measures of glutamatergic and neuronal metabolism and glial activation influence white matter integrity in bipolar depression. Psychiatry Res Neuroimaging 326: 111534.

[17] Briones-Valdivieso C, Córdova F, Kaune H, et al. (2025) Hormonal and sex-specific functional genomic pathways of genetic risk candidates in autism spectrum disorder: evidence of sex-over-chance effects. Horm Behav 174: 105795.

[18] Brooks NH, Riar I, Klegeris A (2026) Mitochondrial damage-associated molecular patterns: neuroimmunomodulators in central nervous system pathophysiology. Neural Regen Res 21: 1322-38.

[19] Brown R, Benveniste H, Black SE, et al. (2018) Understanding the role of the perivascular space in cerebral small vessel disease. Cardiovasc Res 114: 1462-73.

[20] Bustin A, Witschey WRT, van Heeswijk RB, et al. (2023) Magnetic resonance myocardial T1 ρ mapping: technical overview, challenges, emerging developments, and clinical applications. J Cardiovasc Magn Reson 25: 34.

[21] Cercignani M (2001) Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 70: 311-7.

[22] Chang L, Munsaka SM, Kraft-Terry S, et al. (2013) Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol 8: 576-93.

[23] Chen T-H, Wang H-C, Chang C-J, et al. (2024) Mitochondrial glutathione in cellular redox homeostasis and disease manifestation. Int J Mol Sci 25: 1314.

[24] Chen Y-L, Huang T-H, Tu P-C, et al. (2025) Soluble interleukin-6 receptor-associated functional connectivity as an indicator of bipolar disorder prognosis. Psychiatry Res 351: 116652.

[25] Cherukara MT, Stone AJ, Chappell MA, et al. (2019) Model-based Bayesian inference of brain oxygenation using quantitative BOLD. Neuroimage 202: 116106.

[26] Chu H, Zhu H, Ma J, et al. (2024) Mitochondrial dysfunction and metabolic indicators in patients with drug-naive first-episode schizophrenia: a case-control study. Neuropsychiatr Dis Treat 20: 2433-42.

[27] Cutando L, Busquets-Garcia A, Puighermanal E, et al. (2013) Microglial activation underlies cerebellar deficits produced by repeated cannabis exposure. J Clin Invest 123: 2816-31.

[28] Dager SR, Corrigan NM, Richards TL, et al. (2008) Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 19: 81-96.

[29] Dmochowska N, Tieu W, Keller MD, et al. (2019) Immuno-PET of innate immune markers CD11b and IL-1 β detects inflammation in murine colitis. J Nucl Med 60: 858-63.

[30] Doney E, Cadoret A, Dion-Albert L, et al. (2022) Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders. Eur J Neurosci 55: 2851-94.

[31] Du F, Zhu X-H, Qiao H, et al. (2007) Efficient in vivo 31P magnetization transfer approach for noninvasively determining multiple kinetic parameters and metabolic fluxes of ATP metabolism in the human brain. Magn Reson Med 57: 103-14.

[32] Dudek KA, Dion-Albert L, Lebel M, et al. (2020) Molecular adaptations of the blood-brain barrier promote stress resilience vs. depression. Proc Natl Acad Sci USA 117: 3326-36.

[33] Dwivedi Y (2020) Cell-type-specific transcriptomic analysis in the dorsolateral prefrontal cortex reveals distinct mitochondrial abnormalities in schizophrenia and bipolar disorder. Am J Psychiatry 177: 1107-9.

[34] Ellison-Wright I, Bullmore E (2009) Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophr Res 108: 3-10.

[35] Feng Y-M, Jia Y-F, Su L-Y, et al. (2013) Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin. Autophagy 9: 1395-406.

[36] Fernandes BS, Williams LM, Steiner J, et al. (2017) The new field of ‘precision psychiatry’. BMC Med 15: 80.

[37] Frye RE, Rincon N, McCarty PJ, et al. (2024) Biomarkers of mitochondrial dysfunction in autism spectrum disorder: a systematic review and meta-analysis. Neurobiol Dis 197: 106520.

[38] Gangadhar BN, Jayakumar PN, Subbakrishna DK, et al. (2004) Basal ganglia high-energy phosphate metabolism in neuroleptic-naive patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. Am J Psychiatry 161: 1304-6.

[39] Geschwind DH, Levitt P (2007) Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 17: 103-11.

[40] Gevezova M, Ivanov Z, Pacheva I, et al. (2024) Bioenergetic and inflammatory alterations in regressed and non-regressed patients with autism spectrum disorder. Int J Mol Sci 25: 8211.

[41] Ghasemi M, Mayasi Y, Hannoun A, et al. (2018) Nitric oxide and mitochondrial function in neurological diseases. Neuroscience 376: 48-71.

[42] Gill T, Watling SE, Richardson JD, et al. (2022) Imaging of astrocytes in posttraumatic stress disorder: a PET study with the monoamine oxidase B radioligand [(11)C]SL25.1188. Eur Neuropsychopharmacol 54: 54-61.

[43] Golomb BA, Erickson LC, Zeeland AAS-V, et al. (2014) Assessing bioenergetic compromise in autism spectrum disorder with 31P magnetic resonance spectroscopy: preliminary report. J Child Neurol 29: 187-93.

[44] Gong L-J, Wang X-Y, Gu W-Y, et al. (2020) Pinocembrin ameliorates intermittent hypoxia-induced neuroinflammation through BNIP3-dependent mitophagy in a murine model of sleep apnea. J Neuroinflammation 17: 337.

[45] Görlach A, Bertram K, Hudecova S, et al. (2015) Calcium and ROS: a mutual interplay. Redox Biol 6: 260-71.

[46] Göttler J, Kaczmarz S, Kallmayer M, et al. (2019) Flow-metabolism uncoupling in patients with asymptomatic unilateral carotid artery stenosis assessed by multi-modal magnetic resonance imaging. J Cereb Blood Flow Metab 39: 2132-43.

[47] Harada N, Nishiyama S, Kanazawa M, et al. (2013) Development of novel PET probes, [18F]BCPP-EF, [18F]BCPP-BF, and [11C]BCPP-EM for mitochondrial complex 1 imaging in the living brain. J Labelled Comp Radiopharm 56: 553-61.

[48] He Y, Yang X, Li Z, et al. (2025) The 4977 Bp deletion of mitochondrial DNA as a potential trait marker for major depressive disorder. Neuropsychiatr Dis Treat 21: 867-73.

[49] Heine VM, Dooves S (2025) Neuroglia in autism spectrum disorders. Handb Clin Neurol 210: 303-11.

[50] Heo H-Y, Wemmie J, Thedens D, et al. (2014) Evaluation of activity-dependent functional pH and T1 ρ response in the visual cortex. Neuroimage 95: 336-43.

[51] Hol EM, Pekny M (2015) Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol 32: 121-30.

[52] Holley CL, Schroder K (2020) The rOX-stars of inflammation: links between the inflammasome and mitochondrial meltdown. Clin Transl Immunology 9: e01109.

[53] Holt IJ, Harding AE, Morgan-Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331: 717-9.

[54] Hu X, Leak RK, Shi Y, et al. (2015) Microglial and macrophage polarization-new prospects for brain repair. Nat Rev Neurol 11: 56-64.

[55] Huang H, Luo Z, Min J, et al. (2025) Targeting neuroinflammation in schizophrenia: a comprehensive review of mechanisms and pharmacological interventions. Int Immunopharmacol 159: 114910.

[56] Insel TR, Cuthbert BN (2015) Medicine. Brain disorders? Precisely. Science 348: 499-500.

[57] Iosifescu DV, Bolo NR, Nierenberg AA, et al. (2008) Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder. Biol Psychiatry 63: 1127-34.

[58] Jain P, Chaney AM, Carlson ML, et al. (2020) Neuroinflammation PET imaging: current opinion and future directions. J Nucl Med 61: 1107-12.

[59] Jeon P, Mackinley M, Dempster K, et al. (2025) Activity-dependent modulation of glutamate, glutamine and glutathione in first-episode schizophrenia: a 7T functional MRS study. Schizophr Res 285: 339-48.

[60] Jung C, Ichesco E, Ratai E-M, et al. (2020) Magnetic resonance imaging of neuroinflammation in chronic pain: a role for astrogliosis? Pain 161: 1555-64.

[61] Kann O, Kovács R (2007) Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292: C641-57.

[62] Kaplan GB, Dadhi NA, Whitaker CS (2023) Mitochondrial dysfunction in animal models of PTSD: relationships between behavioral models, neural regions, and cellular maladaptation. Front Physiol 14: 1105839.

[63] Kato Y, Yokokura M, Iwabuchi T, et al. (2023) Lower availability of mitochondrial complex I in anterior cingulate cortex in autism: a positron emission tomography study. Am J Psychiatry 180: 277-84.

[64] Keren-Shaul H, Spinrad, A, Weiner, A, et al. (2017) A uniquemicroglia type associated with restricting development of Alzheimer’s disease. Cell 169: 1276-1290.e17.

[65] Kéri S (2025) Diffusion basis restricted fraction as a putative magnetic resonance imaging marker of neuroinflammation: histological evidence, diagnostic accuracy, and translational potential. Life (Basel) 15: 1599.

[66] Khaliulin I, Hamoudi W, Amal H (2025) The multifaceted role of mitochondria in autism spectrum disorder. Mol Psychiatry 30: 629-50.

[67] Kim J, Kim HS, Chung JH (2023) Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway. Exp Mol Med 55: 510-9.

[68] Kim ME, Lim Y, Lee JS (2025) Mitochondrial dysfunction and metabolic reprogramming in chronic inflammatory diseases: molecular insights and therapeutic opportunities. Curr Iss Mol Biol 47: 1042.

[69] Kölliker-Frers R, Udovin L, Otero-Losada M, et al. (2021) Neuroinflammation: an integrating overview of reactive-neuroimmune cell interactions in health and disease. Mediat Inflamm 2021: 9999146.

[70] Kreisel T, Frank MG, Licht T, et al. (2014) Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol Psychiatry 19: 699-709.

[71] Lai H, Fan P, Zhang P, et al. (2025) Targeting complement C3 with tanshinone I decreases microglia-mediated synaptic engulfment to exert antidepressant effects. Theranostics 15: 8150-75.

[72] Lai M-C, Lombardo MV, Auyeung B, et al. (2015) Sex/gender differences and autism: setting the scene for future research. J Am Acad Child Adolesc Psychiatry 54: 11-24.

[73] Lappas AS, Ioannou M, Samara MT, et al. (2026) Autophagy in schizophrenia: a continuum from developmental vulnerability to progressive neuronal stress? A scoping review. Schizophr Bull 52: sbaf130.

[74] Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168: 497-505.

[75] Li W, Lan X, Wang C, et al. (2025a) Transcriptional signatures of mitochondrial metabolism predict esketamine-induced rACC structural changes in adolescent major depression. J Am Acad Child Adolesc Psychiatry

[76] Li X, Kong Z, Cai K, et al. (2025b) Neopterin mediates sleep deprivation-induced microglial activation resulting in neuronal damage by affecting YY1/HDAC1/TOP1/IL-6 signaling. J Adv Res 72: 181-95.

[77] Liddelow SA, Guttenplan KA, Clarke LE, et al. (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541: 481-7.

[78] Lin DD, Crawford TO, Barker PB (2003) Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR Am J Neuroradiol 24: 33-41.

[79] Liu J, Ma X, Xu W, et al. (2026) Recent developments in imaging transcriptomics for psychiatric disorders. Psychoradiology 6: kkag010.

[80] Liu Y, Gu Y, Yu X (2017) Assessing tissue metabolism by phosphorous-31 magnetic resonance spectroscopy and imaging: a methodology review. Quant Imaging Med Surg 7: 707-26.

[81] Luo Y, Liao C, Chen L, et al. (2022) Heroin addiction induces axonal transport dysfunction in the brain detected by in vivo MRI. Neurotox Res 40: 1070-85.

[82] Machado-Vieira R, Zanetti MV, Otaduy MC, et al. (2017) Increased brain lactate during depressive episodes and reversal effects by lithium monotherapy in drug-naive bipolar disorder: a 3-T 1H-MRS study. J Clin Psychopharmacol 37: 40-5.

[83] Maes M, Almulla AF, You Z, et al. (2025) Neuroimmune, metabolic and oxidative stress pathways in major depressive disorder. Nat Rev Neurol 21: 473-89.

[84] Magnotta VA, Heo H-Y, Dlouhy BJ, et al. (2012) Detecting activity-evoked pH changes in human brain. Proc Natl Acad Sci USA 109: 8270-3.

[85] Magnotta VA, Xu J, Fiedorowicz JG, et al. (2022) Metabolic abnormalities in the basal ganglia and cerebellum in bipolar disorder: a multi-modal MR study. J Affect Disord 301: 390-9.

[86] Maier S, Nickel K, Lange T, et al. (2023) Increased cerebral lactate levels in adults with autism spectrum disorders compared to non-autistic controls: a magnetic resonance spectroscopy study. Mol Autism 14: 44.

[87] Mamah D, Patel A, Chen S, et al. (2025) Diffusion basis spectrum imaging of white matter in schizophrenia and bipolar disorder. Brain Imaging Behav 19: 1002-17.

[88] Manji H, Kato T, Di Prospero NA, et al. (2012) Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13: 293-307.

[89] Mansur A, Rabiner EA, Comley RA, et al. (2020) Characterization of 3 PET tracers for quantification of mitochondrial and synaptic function in healthy human brain: (18)F-BCPP-EF, (11)C-SA-4503, and (11)C-UCB-J. J Nucl Med 61: 96-103.

[90] Medina CS, Biris O, Falzone TL, et al. (2017) Hippocampal to basal forebrain transport of Mn(2+) is impaired by deletion of KLC1, a subunit of the conventional kinesin microtubule-based motor. Neuroimage 145: 44-57.

[91] Mehrhof SZ, Fleming H, Nord CL (2025) An interoceptive model of energy allostasis linking metabolic and mental health. Sci Adv 11: eady4356.

[92] Meier SR, Sehlin D, Syvänen S (2022) Passive and receptor mediated brain delivery of an anti-GFAP nanobody. Nucl Med Biol 114-115: 121-7.

[93] Mescher M, Merkle H, Kirsch J, et al. (1998) Simultaneous in vivo spectral editing and water suppression. NMR Biomed 11: 266-72.

[94] Mizuno Y, Carreira Figueiredo I, Pillinger T, et al. (2026) Immune alterations in schizophrenia and the effects of a therapeutic antibody: a neuroimaging study. Brain 149: 620-31.

[95] Mogensen FL, Delle C, Nedergaard M (2021) The glymphatic system (en)during inflammation. Int J Mol Sci 22: 7491.

[96] Morris G, Berk M (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med 13: 68.

[97] Morris G, Walder K, McGee SL, et al. (2017) A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev 74: 1-20.

[98] Mueller C, Nenert R, Catiul C, et al. (2024) Brain metabolites are associated with sleep architecture and cognitive functioning in older adults. Brain Commun 6: fcae245.

[99] Müller N (2018) Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr Bull 44: 973-82.

[100] Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417: 1-13.

[101] Nagai Y, Kirino E, Tanaka S, et al. (2024) Functional connectivity in autism spectrum disorder evaluated using rs-fMRI and DKI. Cereb Cortex 34: 129-45.

[102] Naik R, Cha H, Shen F, et al. (2025) PET radiotracer targeting the complement C3a receptor. Nucl Med Biol 150-151: 109093.

[103] Nutma E, Stephenson JA, Gorter RP, et al. (2019) A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain 142: 3440-55.

[104] O’Brien JT, Jalilvand SP, Suji NA, et al. (2024) Elevations in the mitochondrial matrix protein cyclophilin D correlate with reduced parvalbumin expression in the prefrontal cortex of patients with schizophrenia. Schizophr Bull 50: 1197-207.

[105] Ochocka N, Kaminska B (2021) Microglia diversity in healthy and diseased brain: insights from single-cell omics. Int J Mol Sci 22: 3027.

[106] Orihuela R, Mcpherson CA, Harry GJ (2016) Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 173: 649-65.

[107] Owen DR, Guo Q, Rabiner EA, et al. (2015) The impact of the rs6971 polymorphism in TSPO for quantification and study design. Clinical and Translational Imaging 3: 417-22.

[108] Paolicelli RC, Sierra A, Stevens B, et al. (2022) Microglia states and nomenclature: a field at its crossroads. Neuron 110: 3458-83.

[109] Peng B, Wang X, Tang T, et al. (2025) The ROS/NLRP3 axis in autophagy regulation: implications for inflammatory bowel disease pathogenesis and therapy. Nat Cell Sci 3: 15-26.

[110] Podgórska J, Pasicz K, Zagórowicz E, et al. (2021) Intravoxel incoherent motion MRI in evaluating inflammatory activity in ulcerative colitis: a pilot study. Acta Radiol 62: 439-46.

[111] Posse S, Otazo R, Dager SR, et al. (2013) MR spectroscopic imaging: principles and recent advances. J Magn Reson Imaging 37: 1301-25.

[112] Prabakaran S, Swatton JE, Ryan MM, et al. (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9: 684-97, 643.

[113] Purcell RH, Sefik E, Werner E, et al. (2023) Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion. Sci Adv 9: eadh0558.

[114] Rahayel S, Tremblay C, Vo A, et al. (2023) Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies. Brain 146: 3301-18.

[115] Rangaraju V, Calloway N, Ryan TA (2014) Activity-driven local ATP synthesis is required for synaptic function. Cell 156: 825-35.

[116] Rappeneau V, Wilmes L, Touma C (2020) Molecular correlates of mitochondrial dysfunctions in major depression: evidence from clinical and rodent studies. Mol Cell Neurosci 109: 103555.

[117] Rejc L, Gómez-Vallejo V, Joya A, et al. (2022) Longitudinal evaluation of neuroinflammation and oxidative stress in a mouse model of Alzheimer disease using positron emission tomography. Alzheimers Res Ther 14: 80.

[118] Rius-Pérez S, Torres-Cuevas I, Millán I, et al. (2020) PGC-1 α, inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev 2020: 1452696.

[119] Roberts RC (2021) Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies. Mitochondrion 56: 91-101.

[120] Rossignol DA, Frye RE (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17: 290-314.

[121] Rusjan PM, Wilson AA, Miler L, et al. (2014) Kinetic modeling of the monoamine oxidase B radioligand [11C]SL25.1188 in human brain with high-resolution positron emission tomography. J Cereb Blood Flow Metab 34: 883-9.

[122] Russo A, Örzsik B, Yalin N, et al. (2024) Altered oxidative neurometabolic response to methylene blue in bipolar disorder revealed by quantitative neuroimaging. J Affect Disord 362: 790-8.

[123] Saccaro LF, Tassone M, Tozzi F, et al. (2024) Proton magnetic resonance spectroscopy of N-acetyl aspartate in first depressive episode and chronic major depressive disorder: a systematic review and meta-analysis. J Affect Disord 355: 265-82.

[124] Saha RN, Pahan K (2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8: 929-47.

[125] Samavati L, Lee I, Mathes I, et al. (2008) Tumor necrosis factor alpha inhibits oxidative phosphorylation through tyrosine phosphorylation at subunit I of cytochrome c oxidase. J Biol Chem 283: 21134-44.

[126] Sanaei Nezhad F, Anton A, Parkes LM, et al. (2017) Quantification of glutathione in the human brain by MR spectroscopy at 3 Tesla: comparison of PRESS and MEGA-PRESS. Magn Reson Med 78: 1257-66.

[127] Scarf AM, Kassiou M (2011) The translocator protein. J Nucl Med 52: 677-80.

[128] Schneider T (2017) Sensitivity of multi-shell NODDI to multiple sclerosis white matter changes: a pilot study. Funct Neurol 32: 97-101.

[129] Setiawan E, Attwells S, Wilson AA, et al. (2018) Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry 5: 339-47.

[130] Sharma E, Fotooh Abadi L, Kombe Kombe JA, et al. (2025) Overview of methods that determine mitochondrial function in human disease. Metabolism 170: 156300.

[131] Simpson D, Gharehgazlou A, Da Silva T, et al. (2022) In vivo imaging translocator protein (TSPO) in autism spectrum disorder. Neuropsychopharmacology 47: 1421-7.

[132] Statharakos N (2025) Link between the mechanism of mitophagy and schizophrenia: a narrative review. Psychiatriki 36: 229-35.

[133] Su L, Cai Y, Xu Y, et al. (2014) Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry 14: 321.

[134] Taseva T, Koycheva Y, Racheva R, et al. (2025) Altered mitochondrial DNA copy number and telomere length in patients with substance use disorder: correlation with age, sex, and chronic diseases. Biochem Genet 63: 5155-74.

[135] Tay TL, Béchade C, D’Andrea I, et al. (2017) Microglia gone rogue: impacts on psychiatric disorders across the lifespan. Front Mol Neurosci 10: 421.

[136] Tkáˇc I, Andersen P, Adriany G, et al. (2001) In vivo 1H NMR spectroscopy of the human brain at 7 T. Magn Reson Med 46: 451-6.

[137] Tseng C-EJ, Canales C, Marcus RE, et al. (2024) In vivo translocator protein in females with autism spectrum disorder: a pilot study. Neuropsychopharmacology 49: 1193-201.

[138] Tseng C-EJ, Guma E, McDougle CJ, et al. (2025) Regional skull translocator protein elevation in autistic adults detected by PET-MRI. Brain Behav Immun 126: 70-9.

[139] Tsukada H, Kanazawa M, Ohba H, et al. (2016) PET imaging of mitochondrial complex I with 18F-BCPP-EF in the brains of MPTP-treated monkeys. J Nucl Med 57: 950-3.

[140] Tsukada H, Nishiyama S, Fukumoto D, et al. (2014a) Novel PET probes 18F-BCPP-EF and 18F-BCPP-BF for mitochondrial complex I: a PET study in comparison with 18F-BMS-747158-02 in rat brain. J Nucl Med 55: 473-80.

[141] Tsukada H, Ohba H, Nishiyama S, et al. (2014b) PET imaging of ischemia-induced impairment of mitochondrial complex I function in monkey brain. J Cereb Blood Flow Metab 34: 708-14.

[142] Verkhratsky A, Nedergaard M (2018) Physiology of Astroglia. Physiol Rev 98: 239-389.

[143] Volkow ND, Fowler JS, Wang G-J, et al. (2010) Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage 49: 2536-43.

[144] Wang D, Chen J, Ying Y, et al. (2024) Assessment of hypoxia and its dynamic evolution in glioblastoma via qBOLD MRI: a comparative study with metformin treatment. Eur Radiol Exp 8: 134.

[145] Wang D, Li Z, Liu W, et al. (2018) Differential mitochondrial DNA copy number in three mood states of bipolar disorder. BMC Psychiatry 18: 149.

[146] Wang Y-F, Chen C-Y, Yang X, et al. (2025) Mitochondrial metabolic reprogramming of microglia in neuroinflammation: implications for major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 143: 111566.

[147] Watling SE, Gill T, Gaudette EV, et al. (2023) Investigating TSPO levels in occupation-related posttraumatic stress disorder. Sci Rep 13: 4970.

[148] Wei Y-H, Lu C-Y, Lee H-C, et al. (1998) Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci 854: 155-70.

[149] West AP, Shadel GS (2017) Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol 17: 363-75.

[150] West AP, Shadel GS, Ghosh S (2011) Mitochondria in innate immune responses. Nat Rev Immunol 11: 389-402.

[151] Wigstrom TP, Roytman S, Bohnen JLB, et al. (2024) Impaired mitochondrial function in bipolar disorder and alcohol use disorder: a case study using (18)F-BCPP-EF PET imaging of mitochondrial complex I. Psychoradiology 4: kkae014.

[152] Yakes FM, Van Houten B (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA 94: 514-9.

[153] Yang G, Xu X, Gao W, et al. (2025) Microglia-orchestrated neuroinflammation and synaptic remodeling: roles of pro-inflammatory cytokines and receptors in neurodegeneration. Front Cell Neurosci 19: 1700692.

[154] Ye J, Duan C, Han J, et al. (2025) Peripheral mitochondrial DNA as a neuroinflammatory biomarker for major depressive disorder. Neural Regen Res 20: 1541-54.

[155] Yirmiya R, Goshen I (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 25: 181-213.

[156] Zeng H, Wu X, Song F, et al. (2016) Synthesis and evaluation of [(18)F]-fluoromethyl triphenylphosphonium cation as a novel mitochondria-specific positron emission tomography tracer. Eur J Med Chem 118: 90-7.

[157] Zhang H, Schneider T, Wheeler-Kingshott CA, et al. (2012) NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. Neuroimage 61: 1000-16.

[158] Zhang W, Wang T, Li L, et al. (2025a) The role of mitochondrial dysfunction-mediated changes in immune cytokine expression in the pathophysiology and treatment of major depressive disorder. Mol Neurobiol 62: 9817-28.

[159] Zhang X, Hatoum L, Ying J, et al. (2025b) Assessing glymphatic-associated fluid dynamics in psychiatric disorders: evidence from neuroimaging-a review. Psychoradiology 5: kkaf031.

[160] Zhang Y, Yuan X, Zhang Y, et al. (2025c) White matter hyperintensities, inflammation and cognitive impairments in drug-naive first episode schizophrenia patients: a cross-sectional study. BMC Psychiatry 25: 462.

[161] Zhang Y-M, Wang Y-T, Wei R-M, et al. (2024) Mitochondrial antioxidant elamipretide improves learning and memory impairment induced by chronic sleep deprivation in mice. Brain Behav 14: e3508.

[162] Zhang Z, Kang W, Mi Y, et al. (2025d) The microbiota-gut-brain axis in autism: associations, causal inference, and interventions-a narrative review. Pathogens 14: 1145.

[163] Zhao K, Zhang Y, Yang S, et al. (2025) Neuroinflammation and stress-induced pathophysiology in major depressive disorder: mechanisms and therapeutic implications. Front Cell Neurosci 19: 1538026.

[164] Zhou Y, Zou Y, Zhong X, et al. (2026) Development of a novel HDAC6 PET imaging agent uncovers associations between HDAC6 overexpression and neuroinflammation in depression. Redox Biol 90: 104014.

[165] Zhu Y, Zhang J, Deng Q, et al. (2024) Mitophagy-associated programmed neuronal death and neuroinflammation. Front Immunol 15: 1460286.

[166] Zürcher NR, Loggia ML, Mullett JE, et al. (2021) [(11)C]PBR28 MR-PET imaging reveals lower regional brain expression of translocator protein (TSPO) in young adult males with autism spectrum disorder. Mol Psychiatry 26: 1659-69.